NYSE
$241.85▲ 0.11%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $26.77BShares out 1.100M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
29- 1d agoAfter-hours26.10.24 08:334Ownership#●●●
QUEST DIAGNOSTICS INC
Robert B. Carter, an insider at Quest Diagnostics, filed a Form 4 on October 23, 2026, reporting changes in beneficial ownership of securities as of October 21, 2026. This filing serves as a standard disclosure of insider equity transactions.…more
$241.85+0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 1d agoAfter-hours26.10.24 08:334Ownership
QUEST DIAGNOSTICS INC
Insider Sam Sam of Quest Diagnostics filed a Form 4 on October 23, 2026, reporting changes in beneficial ownership of securities as of October 21, 2026. This filing serves as a standard disclosure of executive equity transactions.…more
$241.85+0.11%vs prev closeView filingShare - 1d agoAfter-hours26.10.24 08:324Ownership
QUEST DIAGNOSTICS INC
Vicky B. Gregg, an executive at Quest Diagnostics, reported a change in beneficial ownership of company securities on October 21, 2026. This filing serves as a formal disclosure of insider transaction activity via Form 4.…more
$241.85+0.11%vs prev closeView filingShare
28 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 2d agoRegular26.10.23 01:49Bullish#●●●#●●●
Quest Diagnostics Beats Q3 Estimates and Raises Guidance
Quest Diagnostics reported third-quarter results that surpassed Wall Street expectations, leading the company to raise its full-year revenue and earnings guidance. However, the stock faced downward pressure following the disclosure of a cybersecurity breach in its Quanum system.…more
$241.85+0.11%vs prev closeDetected5m · 30m · 60m · Next dayPLUSShareBenzinga
- 3d agoPre-market26.10.22 19:48
●●●●●●●● ●●●●● ●●●●●●
Quest Diagnostics reported third-quarter adjusted EPS of $3.00 and revenue of $3.097 billion, both exceeding analyst expectations. The results reflect a solid year-over-year growth in both profitability and sales.…more
$241.85+0.11%vs prev closeShareBenzinga - 9.22Pre-market26.09.22 21:10
●●●●●●●● ●●●●● ●●●●●●
The CMS plans to align Medicare laboratory payment rates with private sector pricing, aiming to save taxpayers $1 billion annually starting in 2027. This regulatory shift is expected to impact the revenue margins of major diagnostic laboratory providers like Quest Diagnostics.…more
$241.85+0.11%vs prev closeShareBenzinga
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report